Pharmaceutical Manufacturing Equipment Market Size and Share Overview
The Pharmaceutical Manufacturing Equipment Market is estimated to be valued at USD 15.6 billion in 2025 and is projected to reach USD 29.1 billion by 2035, registering a compound annual growth rate (CAGR) of 6.4% over the forecast period.
Rationale for Segmental Growth in the Pharmaceutical Manufacturing Equipment Market
Market Overview:
The pharmaceutical manufacturing equipment market is registering strong growth, driven by expanding drug production capacities, increasing biopharmaceutical output, and advancements in process automation. Rising demand for precision-engineered systems capable of ensuring consistent product quality has reinforced equipment investments across global manufacturing sites.
The market benefits from stricter regulatory standards emphasizing compliance, safety, and process validation, encouraging modernization of production lines. The shift toward continuous manufacturing and integration of smart technologies has enhanced operational efficiency and reduced downtime.
Additionally, the expansion of generic drug production and bioprocessing facilities in emerging markets supports sustained demand. With ongoing pharmaceutical innovation and rising therapeutic demand, the market outlook remains positive, underpinned by technological upgrades and global capacity expansion initiatives..
Quick Stats for Pharmaceutical Manufacturing Equipment Market
- Pharmaceutical Manufacturing Equipment Market Industry Value (2025): USD 15.6 billion
- Pharmaceutical Manufacturing Equipment Market Forecast Value (2035): USD 29.1 billion
- Pharmaceutical Manufacturing Equipment Market Forecast CAGR: 6.4%
- Leading Segment in Pharmaceutical Manufacturing Equipment Market in 2025: Processing Equipment (72.4%)
- Key Growth Region in Pharmaceutical Manufacturing Equipment Market: North America, Asia-Pacific, Europe
- Top Key Players in Pharmaceutical Manufacturing Equipment Market: GEA Group, I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P.A., Syntegon Technology GmbH, ACG (India), Thermo Fisher Scientific Inc., Merck KGaA, Sartorius Stedim Biotech, Bosch Packaging Technology, Buhler Group, Rockwell Automation, Siemens AG, Danaher Corporation
| Metric | Value |
|---|
| Pharmaceutical Manufacturing Equipment Market Estimated Value in (2025 E) | USD 15.6 billion |
| Pharmaceutical Manufacturing Equipment Market Forecast Value in (2035 F) | USD 29.1 billion |
| Forecast CAGR (2025 to 2035) | 6.4% |
Segmental Analysis:
The market is segmented by Type and Application and region.
By Type, the market is divided into Processing Equipment and Packaging Equipment.
In terms of Application, the market is classified into Pharmaceutical Company and Others.
Regionally, the market is classified into North America, Latin America, Western Europe, Eastern Europe, Balkan & Baltic Countries, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific, and the Middle East & Africa.
Insights into the Processing Equipment Segment:
The processing equipment segment leads the type category with approximately 72.40% share of the pharmaceutical manufacturing equipment market. This dominance is attributed to its critical role in drug formulation, mixing, granulation, and drying processes.
The segment benefits from rising demand for advanced, high-throughput systems that ensure consistent dosage uniformity and contamination-free operations. Integration of automation and data analytics into processing machinery has improved process control and efficiency.
Biopharmaceutical manufacturing expansion has further driven the need for specialized equipment designed for sterile operations. As pharmaceutical companies prioritize scalable and compliant production systems, the processing equipment segment is expected to sustain its leading position..
Insights into the Pharmaceutical Company Segment:
The pharmaceutical company segment dominates the application category, accounting for approximately 81.30% share of the market. This segment’s leadership reflects extensive investment in manufacturing infrastructure by both established and emerging pharmaceutical firms.
Increasing production of vaccines, biologics, and small-molecule drugs has necessitated continuous equipment upgrades. Regulatory expectations for quality assurance and GMP compliance further drive modernization across production facilities.
Global supply chain diversification and government incentives for domestic drug manufacturing have supported large-scale adoption of advanced equipment. With sustained industry expansion and continuous R&D investment, the pharmaceutical company segment is projected to maintain its market dominance..
Opportunities Driving Growth in the Pharmaceutical Manufacturing Equipment Industry
- The rising adoption of automation and robotics in pharmaceutical manufacturing processes.
- Automation and robotics have proven to be highly efficient in reducing errors and minimizing wastage, and this has led to increased adoption by manufacturers.
- The adoption of artificial intelligence (AI) and machine learning (ML) technologies in pharmaceutical manufacturing is expected to create new growth opportunities for manufacturers.
Challenges Affecting the Pharmaceutical Manufacturing Equipment Sector
- The need to keep up with ever-changing regulations and compliance requirements.
- The pharmaceutical industry is heavily regulated, and manufacturers must adhere to strict standards to ensure the safety and efficacy of their products. This requires significant investment in research and development, as well as ongoing training and education to stay updated with new regulations.
- Rising need to stay ahead of the curve regarding new technologies and innovations.
- As new equipment and machinery are developed, manufacturers must be able to quickly adapt and integrate these new technologies into their existing processes to stay competitive.
- Manufacturers in the pharmaceutical manufacturing equipment market must be able to effectively manage their supply chain and production processes to ensure timely delivery of products.
- It requires close collaboration with suppliers, as well as effective management of inventory and production schedules.
Pharma Equipment Industry Analysis by Top Investment Segments
The Processing Equipment Segment Dominates the Market by Product Type
| Attributes |
Details |
| Product Type |
Processing Equipment |
| Market CAGR from 2025 to 2035 |
6.1% |
- The growing trend toward automation and digitization of the pharmaceutical manufacturing process also drives the demand for processing equipment.
- The increasing demand for pharmaceuticals worldwide is driving the growth of the segment. This is leading to a surge in the production of drugs, which requires advanced processing equipment to ensure efficiency, accuracy, and quality.
- The processing equipment segment includes a wide range of equipment used in various stages of the manufacturing process, such as mixing, granulation, drying, and milling. This versatility makes it a crucial component of the pharmaceutical manufacturing process, contributing to its dominance in the market.
- The use of chemically strengthened glass in automotive and architectural applications is also on the rise, as it provides better protection and strength compared to traditional glass.
The Pharmaceutical Company Segment Dominates the Market by Application Type
| Attributes |
Details |
| Application |
Pharmaceutical Company |
| Market CAGR from 2025 to 2035 |
5.9% |
- The dominance of pharmaceutical companies in the equipment market is due to stringent regulations and standards in the industry.
- Regulations require a high level of quality control and assurance, which can be difficult for smaller companies to achieve.
- Pharmaceutical companies, on the other hand, have the resources and experience to comply with these regulations and maintain their reputation for safety and efficacy.
- Pharmaceutical companies have the financial resources to invest in the latest technology and equipment, allowing them to stay ahead of the competition and produce pharmaceuticals more efficiently.
- They also have well-established networks and partnerships with suppliers, which gives them an advantage in securing the necessary raw materials for production.
Analysis of Leading Countries in Pharmaceutical Manufacturing Equipment Adoption
| Countries |
CAGR through 2025 to 2035 |
| United States |
6.5% |
| United Kingdom |
7.7% |
| China |
6.9% |
| Japan |
7.3% |
| South Korea |
7.5% |
Rise in Chronic Diseases in the United States
- The demand for drugs that treat age-related conditions such as diabetes, heart disease, and Alzheimer's disease has increased. This has led to a greater need for pharmaceutical manufacturing equipment that can produce these drugs in large quantities.
- The rise in chronic diseases such as cancer, HIV/AIDS, and autoimmune disorders has also contributed to the growth of the pharmaceutical manufacturing equipment market in the United States.
- Above diseases require specialized drugs, often in combination with other medications, which can be difficult and expensive to produce. As a result, pharmaceutical companies have invested heavily in new equipment and technologies that can help them produce these drugs more efficiently.
- The need for more complex and specialized drugs. As drug development becomes more focused on precision medicine and personalized therapies, pharmaceutical companies require equipment to produce drugs with greater specificity and accuracy.
Increasing Investments in Research and Development in the United Kingdom
- The development of new and innovative equipment has led to increased efficiency and productivity in the manufacturing process. This has helped reduce costs and produce high-quality medicines, which is of utmost importance in the pharmaceutical industry.
- The government has been actively supporting the development of new drugs and treatments, which has led to an increased demand for manufacturing equipment.
- The rise of biopharmaceuticals and the demand for more personalized medicine has further fuelled the growth in the market.
- The UK's strong position in the global pharmaceutical market and its reputation for quality and innovation have also contributed to the growth in demand for pharmaceutical manufacturing equipment.
- The country has a highly skilled workforce and world-class manufacturing facilities, making it an attractive destination for pharmaceutical companies looking to expand their manufacturing capabilities.
Growing Interest in Automation and Digitalization in the Pharmaceutical Manufacturing Industry in China
- The rising middle class in China is also increasing demand for healthcare, which further fuels the demand for pharmaceutical manufacturing equipment.
- In recent years, the government has invested heavily in healthcare infrastructure, including building new hospitals and increasing funding for research and development.
- There has been a shift towards specialized manufacturing equipment, as companies seek to produce more complex and customized products in China.
- The growing interest in automation and digitalization in the pharmaceutical manufacturing industry in China which is driving demand for advanced equipment that can integrate with these technologies.
Well-Developed Pharmaceutical Industry in Japan
- The aging population in Japan has led to an increased demand for pharmaceuticals and medical devices. This has, in turn, led to increased investment in the pharmaceutical manufacturing sector, driving demand for equipment such as tablet presses, capsule filling machines, and packaging equipment.
- The growth has been driven by increasing demand for innovative drugs and medical devices, as well as the government's efforts to promote the industry. With this growth, there has been a corresponding increase in demand for manufacturing equipment to support the production of these drugs.
- As a result, there is a strong emphasis on ensuring that all pharmaceuticals and medical devices meet the highest standards of quality and safety. This has led to increased demand for advanced manufacturing equipment that can produce high-quality products in a safe and efficient manner.
Increasing Demand for Generic Drugs in South Korea
- The South Korean government has been actively promoting the development of the pharmaceutical industry, aiming to enhance the country's competitiveness in the global market.
- The government has been providing various incentives and support measures to local manufacturers, which has resulted in a boost in investment in the pharmaceutical manufacturing sector.
- As the government has been encouraging the use of generic drugs to reduce healthcare costs, many pharmaceutical companies are investing in the development of generic drugs, leading to an increase in demand for manufacturing equipment.
Competitive Landscape and Market Dynamics
The market is highly competitive, with several key players vying for market share. With the increasing demand for advanced manufacturing equipment and the growing pharmaceutical industry, competition in the market is expected to remain fierce in the coming years.
In 2025, GEA Group unveiled its latest Pharma 4.0 manufacturing platform to enhance efficiency and flexibility for pharmaceutical manufacturers. The platform comprises novel equipment, including digital replicas of manufacturing processes and quality control systems powered by artificial intelligence.
Key Companies in the Pharmaceutical Manufacturing Equipment Market
- GEA Group
- I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P.A.
- Syntegon Technology GmbH
- ACG (India)
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Sartorius Stedim Biotech
- Bosch Packaging Technology
- Buhler Group
- Rockwell Automation
- Siemens AG
- Danaher Corporation
Scope and Coverage of the Pharmaceutical Equipment Market Report
- Pharmaceutical Manufacturing Industry Survey
- Future of Pharma Manufacturing Analysis
- Demand for Pharma Product Review
- Pharmaceutical Manufacturing Profit Analysis
- Coverage Of Pharmaceutical Manufacturing Equipment Market in the United Kingdom
- Medical Packaging Market Research
Top Segments Studied in the Pharmaceutical Manufacturing Equipment Market
By Type:
- Processing Equipment
- Packaging Equipment
By Application:
- Pharmaceutical Company
- Others
By Region:
- North America
- Latin America
- East Asia
- South Asia
- Europe
- Oceania
- MEA
Frequently Asked Questions
How big is the pharmaceutical manufacturing equipment market in 2025?
The global pharmaceutical manufacturing equipment market is estimated to be valued at USD 15.6 billion in 2025.
What will be the size of pharmaceutical manufacturing equipment market in 2035?
The market size for the pharmaceutical manufacturing equipment market is projected to reach USD 29.1 billion by 2035.
How much will be the pharmaceutical manufacturing equipment market growth between 2025 and 2035?
The pharmaceutical manufacturing equipment market is expected to grow at a 6.4% CAGR between 2025 and 2035.
What are the key product types in the pharmaceutical manufacturing equipment market?
The key product types in pharmaceutical manufacturing equipment market are processing equipment and packaging equipment.
Which application segment to contribute significant share in the pharmaceutical manufacturing equipment market in 2025?
In terms of application, pharmaceutical company segment to command 81.3% share in the pharmaceutical manufacturing equipment market in 2025.
